< Back to Media Releases


7th June 2018

VOLKETSWIL, Switzerland – 7 June 2018. Yesterday, the German Design Council announced the winners of the first-ever German Innovation Award. Among them was the Andago in the category “Excellence in Business to Business.”

The German Innovation Award is bestowed upon products and solutions whose user-friendliness adds value and sets them apart from the competition. This honor is not limited to a particular sector as innovations that shape the future and improve lives can be found across industries.

“The Andago provides safe, intensive gait therapy at an improved therapist-to-patient ratio,” Hocoma CEO Dr. Gery Colombo said. “We are happy that its excellent performance has been recognized, despite being up against fierce competition. More than 650 products and solutions were submitted, around 60% of which belonging to the B2B category.”

The independent, interdisciplinary jury considered the most innovative, useful, and economical nominees. Other important criteria included social and ecological responsiblity, marketability, or the potential to create jobs.

About the Andago

Hocoma’s Andago is breaking new ground in gait therapy. The mobile system with body weight support senses patients’ movement intentions and actively follows. Rather than relying on multiple therapists to support and secure them, patients can walk independently and freely. The improved therapist-to-patient ratio combats rising health care costs as well as shortages of qualified personnel in rehabilitation.

About the German Design Council

Created by the German Parliament, the German Design Council is Germany’s leading authority on design and brands. It works to promote society’s awareness of design and supports companies on all matters relating to brand and design development.

About Hocoma

About Hocoma Successful therapy begins in the patient’s mind. Firmly believing that they can reach their goals, one step at a time. The Swiss medical technology company Hocoma is committed to successful therapy. Its innovative technologies and ideas lend functional movement therapy new impetus, promote autonomous therapy, and provide for maximal motivation. In the rehabilitation technology field, Hocoma is internationally recognized as a pioneer and market leader. As a Total Solution Provider, we cover the entire continuum of rehabilitation: Our portfolio includes robotic and sensor-based medical devices for early rehabilitation and mobilization, for intensive gait therapy, for arm and hand function recovery, and for lower back pain relief. Additionally, our support packages offer a helping hand with clinical integration and research, business design, financing options, and marketing, and our technical support hotline is available 24/7. Hocoma founder and CEO Dr. Gery Colombo believes: “Those who break new ground must be open-minded towards unusual methods.” We have been living this mission statement since our beginnings in 1996 – at our headquarters in Switzerland as well as our subsidiaries in Chile, Singapore, Slovenia, and the USA. All the while, ideal therapy remains our primary goal. Hocoma has been a proud partner of DIH International and Motek since August 2016. The company belongs to the DIH Rehabilitation Division which collectively generated a 50 million USD turnover in 2017. For more information about Hocoma, please visit www.hocoma.com.

Product Disclaimer

All Hocoma products are medical devices and must be used in strict adherence to the User Manual; failure to do so may result in serious personal injury. It is strongly recommended that you regularly consult Hocoma’s website (www.hocoma.com/legalnotes) for the latest available information. Please contact Hocoma in case of any questions.

Use only under the supervision of qualified medical personnel. However, certain Hocoma products are marketed for home use and must be strictly used according to the recommendations of your medical care provider who is knowledgeable about your specific needs. Consult the User Manual and Hocoma’s website (www.hocoma.com/legalnotes) for appropriate product designation. Failure to obtain and follow the recommendations of your medical care provider may result in serious personal injury.

This information provides details about medical products which may not be available in all countries and may not have received approval or market clearance by all governmental regulatory bodies throughout the world. Nothing herein should be construed as a solicitation or promotion of any product or of an indication of any specific use for any product which is not authorized by the laws and regulations of the country where the reader of this information resides.